Wafik S. El-Deiry, MD PhD FACP · @weldeiry
140 followers · 1562 posts · Server med-mastodon.com

This is where the posters I presented this year at and have ended up for now @BrownUCancer @BrownMedicine @BrownUniversity @BrownOncology @BrownPathology @BrownUPathoGP

#aacr23 #asco23

Last updated 1 year ago

Wafik S. El-Deiry, MD PhD FACP · @weldeiry
140 followers · 1560 posts · Server med-mastodon.com

Delighted to have opportunity yesterday to speak with @GRASPtweets patient advocate mentors, survivors, oncologists & scientists about investigator-initiated trial @BrownOncology BrUOG 387 @BrownUCancer @BrownMedicine @BrownUniversity @LifespanHlthSys @carenewengland @OncoAlert
Our trial builds on >15 year effort in first-in-human combo ER/PR+ Her2- breast cancer & tumors w/ Rb loss. Presented @ASCO appreciate questions & discussion led by GRASP co-founder @itsnot_pink

#MBC #eldeirylab #asco23

Last updated 1 year ago

German Breast Group · @GBG
6 followers · 18 posts · Server med-mastodon.com

In ER positive and HER2 negative detection of circulating tumor DNA (ct DNA) following neoadjuvant chemotherapy and surgery, is associated with a very high risk of early relapse. This suggests also limited efficacy of adjuvant endocrine therapy​. Studies of clinical imaging and of experimental therapy are warranted in this patient population, especially in patients who fail to ‘clear’ ctDNA​.
Presentation slides are available now: gbg.de/de/newsroom/meldungen/2

#breastcancer #asco23

Last updated 1 year ago

German Breast Group · @GBG
6 followers · 17 posts · Server med-mastodon.com

In patients with triple negative RNA expression levels from peripheral immune cells could serve as a minimal-invasive liquid biopsy source to predict response to therapy, survival and immune-related adverse events. RNA expression levels could therefore enable differentiation between patients who might benefit from neoadjuvant immune checkpoint therapy compared to standard therapies.
Presentation slides are available now: gbg.de/de/newsroom/meldungen/2

#breastcancer #asco23

Last updated 1 year ago

Paul Fu, Jr., MD, MPH · @puhfu
55 followers · 4 posts · Server med-mastodon.com

Exciting news from @cityofhope Dr. Alex Herrera at @asco showing nivolumab-AVD poised to be new standard therapy for advanced stage classical Hodgkin lymphoma for both pediatric and adult patients. ascopubs.org/doi/10.1200/ADN.2

#asco23

Last updated 1 year ago

C. Harris Floudas · @chfloudas
88 followers · 858 posts · Server mstdn.social

Fascinating how many investment banking/vc people are present in , taking notes, asking questions etc, with notable interest in trials with designs including endpoints evaluable in the shorter term and leading to approvals (not always intersecting).

#asco23

Last updated 1 year ago

C. Harris Floudas · @chfloudas
91 followers · 889 posts · Server mstdn.social

Fascinating how many investment banking/vc people are present in , taking notes, asking questions etc, with notable interest in trials with designs including endpoints evaluable in the shorter term and leading to approvals (not always intersecting).

#asco23

Last updated 1 year ago

Claire McCarthy · @clairem402
145 followers · 251 posts · Server mstdn.social

at yesterday’s Opening Session, Dr. Eric Winer described the theme of the meeting, which is “Partnering with Patients: The Cornerstone of Clinical Cancer and Research” and shared his own personal health journey.

He also presented lessons related to the importance of partnerships between clinicians and patients:
1) Relationship with health care team is paramount
2) Science matters
3) We all face challenges
4) Responses to illness vary across individuals
5) Stigma can be crushing

#asco23 #icymi

Last updated 1 year ago

Claire McCarthy · @clairem402
154 followers · 283 posts · Server mstdn.social

at yesterday’s Opening Session, Dr. Eric Winer described the theme of the meeting, which is “Partnering with Patients: The Cornerstone of Clinical Cancer and Research” and shared his own personal health journey.

He also presented lessons related to the importance of partnerships between clinicians and patients:
1) Relationship with health care team is paramount
2) Science matters
3) We all face challenges
4) Responses to illness vary across individuals
5) Stigma can be crushing

#asco23 #icymi

Last updated 1 year ago

C. Harris Floudas · @chfloudas
88 followers · 854 posts · Server mstdn.social

Maybe too early, but again this year I notice that posters presenting AI or ML work are very scarce in details about the actual methods.

#asco23

Last updated 1 year ago

C. Harris Floudas · @chfloudas
91 followers · 889 posts · Server mstdn.social

Maybe too early, but again this year I notice that posters presenting AI or ML work are very scarce in details about the actual methods.

#asco23

Last updated 1 year ago

C. Harris Floudas · @chfloudas
87 followers · 852 posts · Server mstdn.social

started for me today in the sunnt Chicago - lots of results to cover and friends to meet and catch-up!

#asco23

Last updated 1 year ago

C. Harris Floudas · @chfloudas
91 followers · 889 posts · Server mstdn.social

started for me today in the sunnt Chicago - lots of results to cover and friends to meet and catch-up!

#asco23

Last updated 1 year ago

Wafik S. El-Deiry, MD PhD FACP · @weldeiry
140 followers · 1498 posts · Server med-mastodon.com

Early this morning I was excited to run into the amazing and inspiring @AmerCancerCEO at the @ASCO meeting in Chicago

Grateful to @AmericanCancer for the unwavering support of cancer research, of patients, and the community

@ACSCAN @ACSCANRI @BrownUCancer @BrownMedicine @BrownUniversity

#asco23

Last updated 1 year ago

Wafik S. El-Deiry, MD PhD FACP · @weldeiry
140 followers · 1494 posts · Server med-mastodon.com

Looking forward to learning and networking over the next few days

#asco23

Last updated 1 year ago

Wafik S. El-Deiry, MD PhD FACP · @weldeiry
140 followers · 1490 posts · Server med-mastodon.com

Gotta meet those deadlines👇

Grant writing on my first flight en route to Chicago for all it takes is being in a quiet place with the needed materials available.

#asco23

Last updated 1 year ago

Wafik S. El-Deiry, MD PhD FACP · @weldeiry
139 followers · 1432 posts · Server med-mastodon.com

As approaches and another year goes by, and as a member of a known but unappreciated immigrant ethnic minority with no disaggregated data from “white,” I am concerned about DEI in the oncology/cancer research workforce and concerned about minority inclusion in cancer clinical trials @ASCO @ASCOPost @drdonsdizon @AACR @DrRobWinn @theNCI @OtisBrawley @TheCancerLetter

#asco23

Last updated 1 year ago

Wafik S. El-Deiry, MD PhD FACP · @weldeiry
136 followers · 1288 posts · Server med-mastodon.com

Looking forward to the @ASCO meeting in June and excited to share our progress and collaborations

lnkd.in/eMdMiTF6

#asco23

Last updated 2 years ago

TumorBoardTuesday · @TumorBoardTuesday
114 followers · 2550 posts · Server mstdn.science

RT @dawood_findakly
@NarjustFlorezMD @TumorBoardTues @MPishvaian @JohnEbbenMDPhD @Empoweringpts9 @ASCO @pashtoonkasi @DrSteveMartin @ShaalanBeg @JineshGheeya @VivekSubbiah @manjuggm Congratulations to on their incredible achievement of being selected for the poster discussion session at ! Your hard work and dedication to advancing cancer research is truly inspiring. Keep up the amazing work! 🎉👏

#TumorBoardTuesday #asco23 #cancerresearch #achievement

Last updated 2 years ago

RT @TumorBoardTues
🎉While we were on hiatus, we received notification of our abstract acceptance for discussion!!

We’re thrilled to bring more awareness of the impact discussions continue to have on knowledge of novel therapies and toxicities in solid tumor oncology!🙏🏼

#asco23 #TumorBoardTuesday

Last updated 2 years ago